Dark

Check out our API

BDSI
BioDelivery Sciences International, Inc.
stock NASDAQ

Inactive

Mar 22, 2022

5.59USD-0.089%(0.00)2,107,479

Pre-market

0.00USD-100.000%(-5.60)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 21, 2022

02:31PM EST Mid-Afternoon Market Update: Crude Oil Drops 2%; Limelight Networks Shares Spike Higher Benzinga

12:31PM EST Mid-Day Market Update: Dow Falls 100 Points; Netflix Shares Plummet Benzinga

06:27AM EST HC Wainwright & Co. Maintains Neutral on BioDelivery Sciences Intl, Raises Price Target to $4.5 Benzinga

Jan 20, 2022

08:05AM EST BioDelivery Sciences Raises FY21 Sales Guidance From $162M-$167M To $165M-$167M Vs. $165.34M Est.; Co. Raises Lower End Of BELBUCA 2021 Net Sales Guidance From $144M-$148M To $147M-$148M Benzinga

08:00AM EST Total 2021 Net Revenue expected in the range of $165 -$167 million, as compared to previous guidance of $162-$167 million GlobeNewswire Inc

Dec 20, 2021

04:28PM EST BioDelivery Sciences Reports US District Court Issued Opinion In Favor Of Co. In Patent Litigation Against Alvogen Benzinga

04:27PM EST BioDelivery Sciences Prevails in BELBUCA ANDA GlobeNewswire Inc

11:53AM EST BioDelivery Sciences Intl Option Alert: Jan 21 $3 Calls Sweep (41) near the Ask: 677 @ $0.499 vs 4602 OI; Ref=$3.1285 Benzinga

Nov 19, 2021

05:01PM EST Biodelivery Sciences Shares Bounce Off Session Lows as Some Traders Passing Around Positive Seeking Alpha Blog Post From Contributor Which Suggests $6 Price Target Benzinga

Nov 4, 2021

10:20AM EDT Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2021 Benzinga

07:16AM EDT HC Wainwright & Co. Downgrades BioDelivery Sciences Intl to Neutral, Lowers Price Target to $4.5 Benzinga

Nov 3, 2021

09:19AM EDT BioDelivery Sciences Intl Cuts FY21 Sales Guidance From $170M-$180M To $162M-$167M Vs. $169.91M Est. Benzinga

09:19AM EDT BioDelivery Sciences Intl Q3 EPS $0.07 Beats $0.05 Estimate, Sales $41.10M Miss $42.04M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

08:00AM EDT Total Net Revenue of $41.1 Million, an Increase of 4% versus Prior Year GlobeNewswire Inc

Oct 21, 2021

12:11PM EDT BioDelivery Sciences Appoints John Golubieski As Chief Financial Officer Benzinga

08:00AM EDT BioDelivery Sciences Appoints John Golubieski as Chief Financial GlobeNewswire Inc

Oct 20, 2021

08:00AM EDT BioDelivery Sciences to Report Third Quarter 2021 Financial GlobeNewswire Inc

Sep 30, 2021

08:00AM EDT The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults GlobeNewswire Inc

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

05:11PM EDT BioDelivery Sciences International Says Filed Motion For Order To Show Cause Why Defendants Should Not Be Held In Contempt For Violating Court Order Of June, 28, 2021 Benzinga

Sep 9, 2021

08:30AM EDT BioDelivery Sciences International Completes Acquisition of GlobeNewswire Inc

Sep 7, 2021

09:30AM EDT BioDelivery Sciences To Exhibit 3 Scientific Posters Comparing BELBUCA To Oxycodone At PAINWeek 2021 Conference Benzinga

09:28AM EDT BioDelivery Sciences International, Inc.(NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will showcase three scientific posters regarding BELBUCA(buprenorphine buccal film), CIII at the PAINWeek 2021 Conferencetaking place September 7 11, 2021 at The Cosmopolitan of Las Vegas. GlobeNewswire Inc

Sep 3, 2021

08:00AM EDT BioDelivery Sciences to Participate in Upcoming Virtual Investor GlobeNewswire Inc

Aug 20, 2021

12:38PM EDT BioDelivery Sciences International Wins $24M Contract From Department Of Veterans Affairs Benzinga

Aug 16, 2021

08:00AM EDT AzurRx BioPharma, Inc. (AzurRx or the Company) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic, therapies forgastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately. The appointment increases the size of AzurRxs Board to seven members. GlobeNewswire Inc

Aug 5, 2021

06:07AM EDT HC Wainwright & Co. Maintains Buy on BioDelivery Sciences Intl, Raises Price Target to $6 Benzinga

Aug 4, 2021

10:44AM EDT Dr. Reddy's Laboratories Limited (RDY) said that it will sell its U.S. and Canada territory rights for ELYXYB (celecoxib oral solution) 25 mg/mL, to BioDelivery Sciences International Inc. (BDSI). RTTNews

09:57AM EDT UPDATE: Dr. Reddy's Says Will Receive $6M Upfront Payment Upon Closing, Followed By $9M Payment On Year After Closing Benzinga

09:55AM EDT Dr. Reddy's Labs Reports Agreement With Biodelivery Sciences To Sell US, Canada Territory Rights For Elyxyb Benzinga

09:03AM EDT BioDelivery Sciences Earlier Reported Q2 EPS $0.09 Beats $0.05 Estimate, Sales $41.44M Miss $42.41M Estimate Benzinga

08:00AM EDT Total Company Net Revenue of $41.4 Million Driven by BELBUCA All-Time High TRx Market Share GlobeNewswire Inc

07:31AM EDT BioDelivery Sciences International To Acquire US And Canadian Rights To ELYXYB From Dr. Reddy's Laboratories For Upfront Payment Of $6M Plus An Additional $9M Benzinga

07:30AM EDT The only FDA-approved, ready-to-use oral solution for the acute treatment of migraine with or without aura in adults GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Aug 3, 2021

11:07AM EDT Earnings Preview For BioDelivery Sciences Intl Benzinga

Jul 22, 2021

08:00AM EDT BioDelivery Sciences to Report Second Quarter 2021 Financial GlobeNewswire Inc

Jun 30, 2021

01:17PM EDT BioDelivery Sciences Intl Option Alert: Sep 17 $4 Calls at the Ask: 2000 @ $0.25 vs 4461 OI; Earnings 8/4 Before Open [est] Ref=$3.59 Benzinga

May 14, 2021

07:59AM EDT The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts Benzinga

May 6, 2021

08:51AM EDT BioDelivery Sciences International Reiterates FY21 Sales Guidance Of $170M-$180M Benzinga

08:49AM EDT BioDelivery Sciences Intl Q1 EPS $0.05 Misses $0.07 Estimate, Sales $41.00M Miss $41.34M Estimate Benzinga

08:00AM EDT Total Company Net Revenue of $41 Million, an Increase of 7% versus Prior YearNet Income of $5.2 Million, EBITDA Margin of 22% and Operating Cash Generation of $11 MillionConference Call and Webcast Scheduled for 8:30 AM EST Today GlobeNewswire Inc

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 20, 2021

08:00AM EDT BioDelivery Sciences to Report First Quarter 2021 Financial GlobeNewswire Inc

Mar 11, 2021

06:40AM EST HC Wainwright & Co. Maintains Buy on BioDelivery Sciences Intl, Lowers Price Target to $5.5 Benzinga

Mar 10, 2021

09:48AM EST BioDelivery Sciences International shares were trading higher after the company reported better-than-expected Q4 EPS and sales results. Benzinga

08:31AM EST Recap: BioDelivery Sciences Q4 Earnings Benzinga

08:09AM EST BioDelivery Sciences Sees FY21 Sales $170M-$180M vs $190.23M Est. Benzinga

08:08AM EST BioDelivery Sciences Intl Q4 GAAP EPS $0.10 Beats $0.06 Estimate, Sales $42.20M Beat $38.72M Estimate Benzinga

08:00AM EST Total Company Net Revenue Increased 40% versus Prior Year to Reach an All-Time High of $156.5 Million GlobeNewswire Inc

07:26AM EST The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link Benzinga

04:04AM EST Earnings Scheduled For March 10, 2021 Benzinga

Mar 9, 2021

10:25AM EST Earnings Preview: BioDelivery Sciences Intl Benzinga

Mar 6, 2021

10:58AM EST The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings Benzinga

Feb 17, 2021

08:00AM EST BioDelivery Sciences to Report Fourth Quarter and Full Year 2020 GlobeNewswire Inc

Feb 11, 2021

08:00AM EST BioDelivery Sciences International, Inc.(NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer, Terry Coelho, to Executive Vice President and Chief Financial Officer. GlobeNewswire Inc

Feb 3, 2021

08:45AM EST An Aging Population is Increasing the Need for Novel Treatments PR Newswire

Jan 15, 2021

09:00AM EST Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory OutcomesComparing BELBUCA to Oxycodone on January 16 from 1:10pm 2:10pm CT GlobeNewswire Inc

Nov 20, 2020

08:30AM EST BioDelivery Sciences to Participate in the Piper Sandler 32nd GlobeNewswire Inc

Nov 11, 2020

08:38AM EST BioDelivery Sciences To Present And Host 1x1 Investor Meetings At Annual Southwest IDEAS Investor Conference Nov. 18 Benzinga

08:30AM EST BioDelivery Sciences to Present Virtually and Host 1x1 Investor GlobeNewswire Inc

Nov 5, 2020

08:05AM EST BioDelivery Sciences Intl Q3 EPS $0.09 Beats $0.05 Estimate, Sales $39.44M Beat $39.35M Estimate Benzinga

07:54AM EST The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 4, 2020

05:32PM EST BioDelivery Sciences Reports $25M Buyback Benzinga

05:14PM EST BioDelivery Sciences Announces Appointment Of Jeff Bailey As Permanent CEO Benzinga

Nov 2, 2020

08:59AM EST Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 23, 2020

08:00AM EDT BioDelivery Sciences to Report Third Quarter 2020 Financial GlobeNewswire Inc

Sep 11, 2020

08:04AM EDT BioDelivery Sciences Reports 5 Scientific Poster Presentations at PAINWeek 2020 National Conference on Pain Management Benzinga

08:00AM EDT BioDelivery Sciences International, Inc.(NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the presentation of five scientific posters highlighting data regarding BELBUCA at the 14th Annual PAINWeek 2020 National Conference on Pain Management taking place virtually September 11-13, 2020. GlobeNewswire Inc

Sep 3, 2020

08:00AM EDT BioDelivery Sciences to Present at Two Upcoming Investor Conferences GlobeNewswire Inc

Aug 5, 2020

08:18AM EDT BioDelivery Sciences Intl Q2 Adj. EPS $0.09 Beats $0.04 Estimate, Sales $36.58M Beat $36.44M Estimate Benzinga

07:45AM EDT Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million GlobeNewswire Inc

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Jul 27, 2020

04:01PM EDT BioDelivery Sciences to Report Second Quarter 2020 Financial GlobeNewswire Inc

Share